Full View

Pneumonia frequency and severity in patients with symptomatic COVID-19: impact of mRNA and adenovirus vector vaccines

S Vicini, D Bellini, A Iannarelli… - American Journal of …, 2022 - Am Roentgen Ray Soc
Please see the Editorial Comment by Brent P. Little discussing this article. BACKGROUND.
Additional evidence of the role of COVID-19 vaccination in reducing pneumonia frequency …
被引用次数：7 相关文章

Pneumonia Frequency and Severity in Patients With Symptomatic COVID-19: Impact of mRNA and Adenovirus Vector Vaccines

S Vicini, D Bellini, A Iannarelli… - AJR. American …, 2022 - pubmed.ncbi.nlm.nih.gov
BACKGROUND. Additional evidence of the role of COVID-19 vaccination in reducing
pneumonia frequency and severity in the setting of breakthrough infection could help …

Pneumonia frequency and severity in patients with symptomatic COVID-19: impact of mRNA and adenovirus vector vaccines

S Vicini, D Bellini, A Iannarelli, M Rengo… - AMERICAN JOURNAL …, 2022 - iris.uniroma1.it
BACKGROUND. Additional evidence of the role of COVID-19 vaccination in reducing
pneumonia frequency and severity in the setting of breakthrough infection could help …

Pneumonia frequency and severity in patients with symptomatic COVID-19: impact of mRNA and adenovirus vector vaccines.

S Vicini, D Bellini, A Iannarelli, M Rengo, G Pelle… - 2022 - cabidigitallibrary.org
BACKGROUND: Additional evidence of the role of COVID-19 vaccination in reducing
pneumonia frequency and severity in the setting of breakthrough infection could help …

Pneumonia Frequency and Severity in Patients With Symptomatic COVID-19: Impact of mRNA and Adenovirus Vector Vaccines.

S Vicini, D Bellini, A Iannarelli, M Rengo… - … . American Journal of …, 2022 - europepmc.org
BACKGROUND. Additional evidence of the role of COVID-19 vaccination in reducing
pneumonia frequency and severity in the setting of breakthrough infection could help …